Analysis of the effect of diabetes type 2 duration on beta cell secretory function and insulin resistance
Diabetes type 2 is a chronic metabolic disorder. Pathogenesis of diabetes type 2 results from the impaired insulin secretion, impaired insulin action and increased endogenous glucose production. Diabetes evolves through several phases characterized by qualitative and quantitative changes of beta cel...
Main Authors: | Popović Ljiljana, Zamaklar Miroslava, Lalić Katarina, Vasović Olga |
---|---|
Format: | Article |
Language: | English |
Published: |
Serbian Medical Society
2006-01-01
|
Series: | Srpski Arhiv za Celokupno Lekarstvo |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2006/0370-81790606219P.pdf |
Similar Items
-
Islets secretory capacity determines glucose homoeostasis in the face of insulin resistance
by: P Wiesli, et al.
Published: (2004-09-01) -
Insulin secretion, insulin sensitivity, and hepatic insulin extraction in first-degree relatives of type 2 diabetic patients
by: W.P. Pimenta, et al.
Published: (2003-03-01) -
Short-term insulin therapy at the time of diagnosis of Type 2 diabetes leads to better glycemic control and improved beta cell function
by: Siddharth Madnani, et al.
Published: (2019-01-01) -
Distinct insulin granule subpopulations implicated in the secretory pathology of diabetes types 1 and 2
by: Alex J B Kreutzberger, et al.
Published: (2020-11-01) -
Assessment of Insulin Secretion and Insulin Resistance in Human
by: So Young Park, et al.
Published: (2021-09-01)